Results 141 to 150 of about 9,499 (196)

In Situ Analytical Chemistry Laboratory for the Exobiology Extant Life Surveyor. [PDF]

ACS Meas Sci Au
Drevinskas T, Cable ML, Stenner C, Gardner AS, Paton M, Malaska MJ, Cruz S, Rieber R, Etheredge R, Robinson M, Ono M, Mora MF, Bagshaw EA, Prior-Jones MR, Ferreira Santos MS, Noell AC, Willis PA.   +16 more
europepmc   +1 more source

Complement and kidney diseases: unlocking the opportunity of targeted treatments for glomerular diseases, including IgA nephropathy. [PDF]

Pediatr Nephrol
Wade J, Thomas DC, Pickering MC, Medjeral-Thomas NR.   +3 more
europepmc   +1 more source

Kidney Allograft Outcomes in Borderline and T Cell-Mediated Rejection With Microvascular Inflammation. [PDF]

Kidney Int Rep
Lim WH, Wang J, Teixeira-Pinto A, Ho J, Gately R, Sabanayagam D, Ooi E, Boroumand F, Bakar KS, Zhu L, Pilmore H, Mulley W, Li J, Nankivell B, Kanellis J, Nickerson P, Wiebe C, Wong G.   +17 more
europepmc   +1 more source

The Diversity of Transplant Glomerulitis and its Relationship to Alloantibody. [PDF]

Kidney Int Rep
Nankivell BJ, Viswanathan S, Ding X, Li JSY.   +3 more
europepmc   +1 more source

A case of overcoming De Novo thrombotic microangiopathy associated with hyperacute rejection in a living donor ABO-incompatible kidney transplantation despite severe intraoperative graft injury. [PDF]

CEN Case Rep
Ide H, Tomita Y, Koizumi M, Ogura G, Nakamura M.   +4 more
europepmc   +1 more source

Kidney biopsy analysis of 14 cases of renal disease after unrelated cord blood transplantation. [PDF]

BMC Nephrol
Mizuta M, Sawa N, Suwabe T, Oba Y, Sekine A, Yamanouchi M, Mizuno H, Inoue N, Tanaka K, Hasegawa E, Wake A, Hoshino J, Kono K, Ohashi K, Yamaguchi Y, Fukuda M, Miyazono M, Wada T, Ubara Y.   +18 more
europepmc   +1 more source

Update on diagnostic and therapeutic strategies for antibody-mediated rejection in kidney transplantation. [PDF]

World J Transplant
Elahi T, Ahmed S, Mubarak M.
europepmc   +1 more source

Layered immune biomarker monitoring in IgA nephropathy: from mucosal IgA dysregulation to precision therapeutic response assessment. [PDF]

Front Med (Lausanne)
Lu Y, Sun C, Zhou X.
europepmc   +1 more source

Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases. [PDF]

Neurol Neuroimmunol Neuroinflamm
Landt C, Held F, Kolotourou K, Guranda M, Vakrakou AG, Franz J, Thomas C, Schmiedeknecht MUH, Bergann K, Wrzos C, Endmayr V, Tsaktanis T, Zechel S, Ancău M, Misgeld T, Hakroush S, Hametner S, Rothhammer V, Höftberger R, Hemmer B, Stadelmann C, Nessler S.   +21 more
europepmc   +1 more source

Lifestyle intervention outcomes in T2DM and the added value of CGM: 6-month results from the Polish cohort of the C4D study. [PDF]

Sci Rep
Ostrowska J, Kobos E, Pietrzak M, Szymczak A, Wiktorzak K, Pisano-González MM.   +5 more
europepmc   +1 more source